Form 4 for PRVA Privia Health Group, Inc.
Accepted 2024-04-04 00:00:00 ET · period of report 2024-04-02 · accession 0001759655-24-000036 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-04-04 | 2024-04-02 | PRVA | Mountcastle David | EVP, CFO | S - Sale | $17.77 | -3,933 | 262.3K | -1% | -$69.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.01 per share | 2024-04-02 | S | D | 3,933 | $17.77 | 262,279 | D | — | — | (F2) On April 5, 2023, the Reporting Person filed a Form 4 ("Original Form 4") that inadvertently did not give effect to a correction in the number of shares of the issuer's common stock directly beneficially owned by the Reporting Person pursuant to a Form 4/A filed on December 20, 2022, which was 215,062 shares as of such date. The holdings reported on this Form 4 properly give cumulative effect to such correction in the Original Form 4 as well all intervening Forms 4 filed by the Reporting Person prior to the date hereof. |